PATENT CLAIM ANALYSIS

Application Number: 15914958
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "094000"]

Abstract:
Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.

Claim (Index 19):
The method of  claim 18 , wherein the cancer is selected from the group consisting of colon cancer, colorectal cancer, gastric cancer, esophageal cancer, head and neck cancer, breast cancer, lung cancer, stomach cancer, liver cancer, gall bladder cancer, pancreatic cancer and leukemia.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 90.0
- Lexical Diversity: 1.26667
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15741202', '15740783', '15740787', '15741205', '15109616']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8509280711851113
- 35 USC 102 Novelty (BERT): 0.5756216538191435
- Combined Prediction Score: 0.8233974294485146
- Mean Citation Score: 447.784362
- Max Citation Score: 508.83127
- Similarity Product: 391.7809611093414

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test